abew4me
7 minutes ago
Blarcamesine in Early Alzheimer Disease Phase 2b/3 Randomized Clinical Trial
Marwan N. Sabbagh, William R. Chezem, Kun Jin, Christopher U Missling, Anavex Life Sciences Research Group
First published: 09 January 2025
Abstract
Background
There are no approve